Skip to main content
Premium Trial:

Request an Annual Quote

Organon Renews, Expands Subscription Deal with Lexicon

NEW YORK, July 26 - Dutch pharmaceutical company Organon had agreed to renew and expand its subscription to Lexicon’s OmniBank library and DNA sequence database, Lexicon Genetics said Thursday.

Under the terms of the deal, Oragnon will have access to Lexicon’s tools through December 2002. In addition, Organon will also have access to Lexicon’s gene knockouts as well as to drug target validation data generated by Lexicon for specified targets.

In exchange, Organon will pay annual technology access fees and research funding of an undisclosed amount.

"We believe that Organon's decision to expand its target validation agreement with us is indicative of the value our partners receive by tapping Lexicon's technology and expertise to discover the in vivo functions of genes," Arthur Sands, CEO of Lexicon, said in a statement.

Driek Vergouwen, managing director of research and development at Organon, said that the deal would provide the company with valuable information about gene function.

"Lexicon's expertise in analyzing key mammalian phenotypic characteristics in gene knockouts will enable Organon to learn more about the functions of genes for the benefit of our drug discovery programs that focus on major human diseases," Vergouwen said.

Lexicon Genetics of The Woodlands, Texas, uses gene knockout technology to determine the functions of genes.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.